Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later
- 1 January 2003
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 188 (1) , 49-55
- https://doi.org/10.1067/mob.2003.98
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A prospective study of the relationship between prediagnostic Human Papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomasBritish Journal of Cancer, 2002
- Efficacy of preventive human papillomavirus vaccinationInternational Journal of STD & AIDS, 2001
- Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasiaJournal of General Virology, 1999
- Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study.Journal of General Virology, 1999
- The Natural History of Human Papillomavirus Type 16 Capsid Antibodies among a Cohort of University WomenThe Journal of Infectious Diseases, 1996
- Seropositivities to Human Papillomavirus Types 16, 18, or 33 Capsids and to Chlamydia trachomatis Are Markers of Sexual BehaviorThe Journal of Infectious Diseases, 1996
- Serum antibody responses against human papillomavirus in relation to tumor characteristics, response to treatment, and survival in carcinoma of the uterine cervixCancer Immunology, Immunotherapy, 1995
- Follow‐up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinomaJournal of Medical Virology, 1995
- Pre‐ and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinomaJournal of Medical Virology, 1992
- Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancerVirology, 1992